SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-000383
Filing Date
2024-01-19
Accepted
2024-01-19 16:30:28
Documents
12
Period of Report
2024-01-19
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K xlo-20240119x8k.htm   iXBRL 8-K 43454
  Complete submission text file 0001558370-24-000383.txt   167915

Data Files

Seq Description Document Type Size
2 EX-101.SCH xlo-20240119.xsd EX-101.SCH 3114
3 EX-101.LAB xlo-20240119_lab.xml EX-101.LAB 16578
4 EX-101.PRE xlo-20240119_pre.xml EX-101.PRE 10708
6 EXTRACTED XBRL INSTANCE DOCUMENT xlo-20240119x8k_htm.xml XML 5045
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40925 | Film No.: 24545994
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)